This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignee: Cancer Research Technology Limited. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2026
Title: Lorna Stewart: Innovator in Therapeutic Compounds
Introduction
Lorna Stewart is a prominent inventor based in London, GB. She has made significant contributions to the field of therapeutic compounds, particularly in the development of triazolo compounds. With a total of 5 patents to her name, her work focuses on innovative solutions for medical challenges.
Latest Patents
Lorna Stewart's latest patents include advancements in [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds. These compounds are designed to inhibit AXL receptor tyrosine kinase function, which plays a crucial role in various diseases, including cancer. The inventions not only encompass the compounds themselves but also pharmaceutical compositions that utilize these compounds for therapeutic purposes.
Career Highlights
Lorna Stewart is associated with Cancer Research Technology Limited, where she continues to push the boundaries of medical research. Her work is instrumental in developing treatments that target proliferative conditions mediated by AXL receptor tyrosine kinase.
Collaborations
Lorna has collaborated with notable colleagues such as Grégoire Alexandre Pavé and James Donald Firth. These partnerships enhance the research and development of her innovative compounds.
Conclusion
Lorna Stewart's contributions to the field of therapeutic compounds exemplify her dedication to advancing medical science. Her innovative patents and collaborations position her as a key figure in the fight against diseases like cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile